USPTO Updates 112 Guidance: Presumption Shift of Functional Limitations Recently, the United States Patent & Trademark Office (USPTO) has announced plans to update their guidance on functional claim language under 112 and will after a period of public input. This update will likely require a more detailed specification for functional claims or result in narrower claims. Under the proposed 112 guidelines, which are aimed […] Continue Reading →
USPTO Updates 101 Guidance: Making Abstract More Concrete Recently the United States Patent & Trademark Office (USPTO) has announced plans to update their guidance on 101 issues and will do so after a period of public input in order to increase clarity during prosecution. This update will replace, not just update, several sections of MPEP 2106. The update will also provide practitioners a […] Continue Reading →
2018 Farm Act has important IP Implications By Heidi Sease Nebel At long last, the 2018 Farm bill has been approved by Congress and forwarded to the President for signature. As I blogged earlier, the bill has important Intellectual Property Implications. The first is that it adds PVP protection for asexually reproduced plants. The addition will allow asexually reproduced plants, which are now protectable under the […] Continue Reading →
CRISPR: Broad Institute Holds onto its Piece of Pie, and it’s Delicious! On Monday, September 10th, the Court of Appeals for the Federal Circuit (CAFC) upheld the decision from the Patent Trial and Appeal Board (PTAB) on the interference between the Broad Institute and the University of California. The PTAB held, and the CAFC upheld, that given the difference between prokaryotic and eukaryotic cells, one skilled in […] Continue Reading →
USPTO Director Andrei Lancu Takes a Look at Early Prosecution This week, the USPTO Director, Andrei Iancu, testified before the House Judiciary Committee. In his written statement Director Iancu wrote on topics related to early prosecution that would result in lower costs to clients and would speed up the process of obtaining a patent. A new pilot program that will allow for a pre-search Examiner […] Continue Reading →
Inter Partes Review Proceedings (IPRs) Do Not Violate Article III of the Constitution per U.S. Supreme Court By Jonathan L. Kennedy The U.S. Supreme held in a 7-2 decision (Justice Gorsuch and Chief Justice Roberts dissenting), Oil States Energy Servs. V. Greene’s Energy Group, LLC, that the Inter Partes Review proceedings, commonly referred to as IPRs, do not violate Article III or the Seventh Amendment. The Court was deciding two primary constitutional challenges: (1) whether IPRs violate […] Continue Reading →
Just Because It’s Nanoscale, Doesn’t Mean It’s Not a Big Deal By Jonathan L. Kennedy Nanotechnology has been taking innovation by storm for decades now and its only increasing its footprint. This is reflected in the growing number of granted patents and published applications directed to nanotechnology inventions. For example, according to StatNano (an organization that monitors and publishing information regarding nanotechnology global developments), more than 20,000 granted patents and […] Continue Reading →
U.S.P.T.O. Remains Open By Kirk M. Hartung Despite the shutdown of a significant portion of the federal government, the United States Patent and Trademark Office will remain open, at least for the short term.This government agency is self-funded through user fees, and therefore will continue business as usual for the next two weeks. If the government shutdown continues into February, the PTO […] Continue Reading →
USPTO Releases Patent Fee Schedule for 2018 This past week, the USPTO released its final patent fee schedule for 2018. The USPTO has been actively seeking to reduce the overall patent pendency, number of unexamined applications, and reduce its appeal backlog. Part of these efforts have been the continual recruiting and training of new examiners and new Administrative Law Judges at the […] Continue Reading →
Federal Circuit Emphasizes “Why” is Important Part of Obviousness Rationales in Chemical Patent Cases In a recent decision by the Federal Circuit Court of Appeals, In re Stepan Company, the Federal Circuit reversed the Patent Trial and Appeal Board decision to affirm an examiner’s rejection that claims were obvious. The claims in the application were directed to ultra-high load, aqueous glyphosate salt-containing concentrates comprising water, a glyphosate salt in […] Continue Reading →